ASSESSMENT OF GLYCEMIC CONTROL IN OUTPATIENT TYPE 2 DIABETIC PATIENTS TREATED WITH INSULIN AT UNIVERSITY MEDICAL CENTER AT HO CHI MINH CITY
DOI:
https://doi.org/10.59354/ydth175.2025.402Keywords:
Type 2 diabetes mellitus, insulin, HbA1c, glycemic controlAbstract
Objective: To determine the proportion of type 2 diabetes mellitus (T2DM) patients treated with outpatient insulin therapy achieving the HbA1c target of < 7% and to investigate associated factors.
Methodology: A cross-sectional study was conducted among 343 T2DM patients receiving outpatient insulin treatment at the Endocrinology Clinic, University Medical Center, Ho Chi Minh City, from January to May 2024. Data including age, gender, BMI, disease characteristics, medications, and laboratory parameters were collected.
Results: The proportion of patients achieving the HbA1c target (<7%) was 16.03%. Factors associated with failure to reach the target included disease duration, dyslipidemia, higher insulin doses, increased frequency of daily insulin injections, and concurrent use of multiple non-insulin antidiabetic drugs. The rate of achieving an HbA1c target of >< 7% is higher in patients with chronic kidney disease.
Conclusion: The low rate of achieving the HbA1c target, especially among patients with longer disease duration, highlights the need for enhanced patient education, support, and optimized therapeutic strategies to improve glycemic control
References
1.Bộ Y tế (2020). Hướng dẫn chẩn đoán và điều trị đái tháo đường típ 2.
2.Hoanh TK (2022). Tỉ lệ đạt mục tiêu đường huyết và các yếu tố liên quan trên bệnh nhân đái tháo đường típ 2 điều trị bằng insulin ở phòng khám ngoại trú. Luận văn bác sĩ nội trú. Đại học Y Duợc Thành phố Hồ Chí Minh.
3.Dong Q, Huang J, Liu S, et al (2019). A survey on glycemic control rate of type 2 diabetes mellitus with different therapies and patients’ satisfaction in China. Patient preference and adherence;13:1303-1310. doi:10.2147/ppa.s198908
4.Ji L-N, Lu J-M, Guo X-H, et al. Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. BMC Public Health. 2013/06/21 2013;13(1):602. doi:10.1186/1471-2458-13-602
5.So WY, Raboca J, Sobrepena L, et al. Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program. Journal of diabetes. Jun 2011;3(2):109-18. doi:10.1111/j.1753- 0407.2011.00115.x
6.Nguyen Thy Khue, Diep BTT, Nguyen VDK, Van Lam H, Tran KQ, Tran NQ. A cross-sectional study to evaluate diabetes management, control and complications in 1631 patients with type 2 diabetes mellitus in Vietnam (DiabCare Asia). International Journal of Diabetes in Developing Countries. 2020/03/01 2020;40(1):70-79. doi:10.1007/ s13410-019-00755-w
7.Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. Apr 2013;1281(1):64- 91. doi:10.1111/nyas.12098
8.Kong APS, Lew T, Lau ESH, et al. Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes, obesity & metabolism. Apr 2020;22(4):669-679. doi:10.1111/dom.13950
9.Pitak P, Tasai S, Kumpat N, et al. The prevalence of glycemic control in patients with type 2 diabetes treated with insulin: a systematic review and meta-analysis. Public Health. Dec 2023;225:218-228. doi:10.1016/j.puhe.2023.10.015
